Articles dans des revues avec comité de lecture (179)
  1. 83. Asselah, T., Ferenci, P., Yu, Y., Redman, R., Pilot-Matias, T., Mobashery, N., Hezode, C., Qaqish, R. R., Elkhashab, M., Hassanein, T., Papatheodoridis, G., Feld, J. J., Moreno, C., & Zeuzem, S. (2016). Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial. The Lancet Gastroenterology and Hepatology, 1(1), 25-35. doi:10.1016/S2468-1253(16)30001-2
  2. 84. Arain, A., Verrando, R., Bruckers, L., Matheï, C., Buntinx, F., van Vlierberghe, H., Francque, S., Laleman, W., Moreno, C., Janssens, F., Nevens, F., Bourgeois, S., Robaeys, G., De Galocsy, C., Henrion, J., Deltenre, P., D'Heygere, F., George, C., Bastens, B., & Van Overbeke, L. (2016). Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. Journal of medical virology, 88(1), 94-99. doi:10.1002/jmv.24308
  3. 85. Buch, S., Stickel, F., Trepo, E., Way, M., Enk, A. H., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., Rietschel, M., McQuillin, A., Frank, J., Kiefer, F., Schreiber, S., Lieb, W., Soyka, M., Semmo, N., Aigner, E., Datz, C., Schmelz, R., Brückner, S., Zeissig, S., Stephan, A.-M., Wodarz, N., Devière, J., Clumeck, N., Sarrazin, C., Lammert, F., Gustot, T., Deltenre, P., Völzke, H., Lerch, M. M., Mayerle, J., Eyer, F., Schafmayer, C., Cichon, S., Nothen, M., Nothnagel, M., Ellinghaus, D., Huse, K., Franke, A., Zopf, S., Hellerbrand, C., Moreno, C., Franchimont, D., Morgan, M. Y., & Hampe, J. (2015). A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nature genetics, 47(12), 1443-1448. doi:10.1038/ng.3417
  4. 86. Marot, A., Trepo, E., Doerig, C., Moreno, C., Moradpour, D., & Deltenre, P. (2015). Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding. Alimentary pharmacology & therapeutics, 42(11-12), 1250-1260. doi:10.1111/apt.13424
  5. 87. Dubuquoy, L., Leteurtre, E., Cannesson-Leroy, A., Dharancy, S., Moreno, C., Pruvot, F. R. E. F., Bataller, R., Mathurin, P., Louvet, A., Lassailly, G., Truant, S., Boleslawski, E., Artru, F., Maggiotto, F., Gantier, E., & Buob, D. (2015). Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut, 64(12), 1949-1960. doi:10.1136/gutjnl-2014-308410
  6. 88. Degré, D., Laleman, W., Verhelst, X., Lamproye, A., Vanwolleghem, T., Gustot, T., Starkel, P., Lanthier, N., Michielsen, P., Delwaide, J., Van Vlierberghe, H., Nevens, F., & Moreno, C. (2015). Multicenter Belgian experience of sofosbuvir medical need program in pre- and post liver transplantation: safety and efficacy results. Transplant international, 28(Supplément 4), 21. doi:10.1111/tri.12700
  7. 89. Coilly, A., Roche, B., Antonini, T. M., Guillaud, O., Lebray, P., Radenne, S., Saouli, A. C., Calmus, Y., Alric, L., Debette-Gratien, M., De Ledinghen, V., Dumortier, J., Durand, F., Duvoux, C., Samuel, D., Duclos-Vallée, J.-C., Botta-Fridlund, D., Latournerie, M., Leroy, V., Pageaux, G.-P., Agostini, H., Giostra, E., & Moreno, C. (2015). Multicenter experience with boceprevir or telaprevir to treat hepatitis C recurrence after liver transplantation: When present becomes past, what lessons for future? PloS one, 10(9), e0138091. doi:10.1371/journal.pone.0138091
  8. 90. Lepida, A., Iraqi, W., DeMasi, R., Lonjon-Domanec, I., Moreno, C., Wedemeyer, H., Colombo, M., Fernández, I., Abdurakhmanov, D., Ferreira, P. A., Strasser, S., Urbanek, P., Mangia, A., & Calleja, J. L. U. J. (2015). Final results of the telaprevir access program: Fibroscan values predict safety and efficacy in hepatitis c patients with advanced fibrosis or cirrhosis. PloS one, 10(9). doi:10.1371/journal.pone.0138503
  9. 91. Deltenre, P., Moradpour, D., Bureau, J.-C., Thabut, D., Trepo, E., Simon-Rudler, M., Monescillo, A., Fraga, M., Denys, A., Doerig, C., Fournier, N., & Moreno, C. (2015). Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: A systematic review and meta-analysis of controlled trials. European journal of gastroenterology & hepatology, 27(9), e1-e9. doi:10.1097/MEG.0000000000000403
  10. 92. Van Gossum, A., Joly, F., Pironi, L., Messing, B., Moreno, C., Colecchia, A., Derrico, A., Demetter, P., De Gos, F., & Cazals-Halem, D. (2015). Transient Elastography (FibroScan) Is Not Correlated with Liver Fibrosis but with Cholestasis in Patients with Long-Term Home Parenteral Nutrition. JPEN. Journal of parenteral and enteral nutrition, 39(6), 719-724. doi:10.1177/0148607114538057
  11. 93. Starkel, P., Vandijck, D., Laleman, W., Van Damme, P., Moreno, C., Blach, S., Razavi, H., & van Vlierberghe, H. (2015). The disease burden of hepatitis c in belgium : An update of a realistic disease control strategy. Acta gastro-enterologica Belgica (Ed. multilingue), 78(2), 228-232.
  12. 94. Ferenci, P., Morano, L. E., Crespo Garcia, C. J., Dufour, J.-F., Bourlière, M., Agarwal, K., Forton, D., Schuchmann, M., Zehnter, E., Nishiguchi, S., Omata, M., Asselah, T., Kukolj, G., Datsenko, Y., Miguel Garcia, V., Scherer, J., Quinson, A. M., Stern, J. J., Foster, G. R., Zeuzem, S., Sarrazin, C., Moreno, C., Ouzan, D., Maevskaya, M., & Calinas, F. (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), 5491, 1246-1255. doi:10.1016/j.jhep.2014.12.024
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>